Evolving use of buprenorphine in the treatment of addiction

Journal of Psychoactive Drugs

Volumn 36, Issue , 2004, Pages 129-137

  Martin, Judith ^a  

^a California Society of Addiction Medicine   (United States)

Author keywords

Buprenorphine; DATA 2000; Office based treatment; Opioid dependence; Physician training

Indexed keywords

BUPRENORPHINE; NARCOTIC ANTAGONIST; LEVACETYLMETHADOL; METHADONE;

ARTICLE; DRUG APPROVAL; HUMAN; LEGAL ASPECT; OPIATE ADDICTION; UNITED STATES; WITHDRAWAL SYNDROME; CONFERENCE PAPER; DRUG FORMULATION; DRUG INDICATION; DRUG TOLERANCE; DRUG WITHDRAWAL; LAW; MEDICAL DOCUMENTATION; METHADONE TREATMENT; PATIENT SELECTION; POSTGRADUATE EDUCATION; PRACTICE GUIDELINE; SOCIAL SUPPORT;

BUPRENORPHINE; DRUG APPROVAL; HUMANS; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; SUBSTANCE WITHDRAWAL SYNDROME; UNITED STATES;

EID: 3042808657     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.2004.10400048     Document Type: Article

References (15)

1. Amass, L.; Kamien, J.B. & Mikulich, S.K. 2001. Thrice-weekly supervised dosing with the combination buprenorphine-naloxone tablet is preferred to daily supervised dosing by opioid-dependent humans. Drug and Alcohol Dependence 61 (2): 173-81.
2. Amass, L.; Kamien, J.B. & Mikulich, S.K. 2000. Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine-naloxone tablet. Drug and Alcohol Dependence 58 (1-2): 143-52.
3. Ball, J.C. & Ross, A. 1991. The Effectiveness of Methadone Maintenance Treatment. New York: Springer-Verlag.
4. Gronbladh, L; Ohlund, L.S. & Gunne, L.M. 1990. Mortality in heroin addiction: Impact of methadone treatment. Acta Psychiatrica Scandinavica 82 (3): 223-27.
5. Johnson, R.E.; Chutuape, M.A.; Strain, E.C.; Walsh, S.L.; Stitzer, M.L. & Bigelow, G.E. 2000. A comparison of levomethadyl acetate, buprenorphine and methadone for opioid dependence. New England Journal of Medicine 343 (18): 1290-97.
6. Joseph, H.; Stancliff, S. & Langrod, L. 2000. Methadone maintenance treatment (MMT): A review of historical and clinical issues. Mount Sinai Journal of Medicine 61 (5-6): 347-64.
7. Joseph, J.; Appel, P. & Schmeider, J. 1981. Deaths During and After Discharge from Methadone Maintenance Treatment: Outcome Study Report #18. Albany, New York: New York State Office of Alcoholism and Substance Abuse Services.
8. Kintz, P. 2001. Deaths involving buprenorphine: A compendium of French cases. Forensic Science lnternational 121 (1-2): 65-69.
9. Ling, W.; Wesson, D. R.;Charuvastra, C. & Klett, C.J. 1996. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Archives of General Psychiatry 53 (5): 401 -07.
10. Magura, S. & Rosenblum, A. 2001. Leaving methadone treatment: Lessons learned, lessons forgotten, lessons ignored. Mount Sinai Journal of Medicine 68 (1): 62-74.
11. McLellan, A.T.; Lewis, D.C.; O'Brien, C.P & Kleber, H.D. 2000. Drug dependence, a chronic medical illness. Journal of the American Medical Association 284 (13): 1689-95.
12. McLellan, A.T.; Arndt, I.O.; Metzger, D.S.; Woody, G.E. & O'Brien, C.P. 1993. The effects of psychosocial services in substance abuse treatment. Journal of the American Medical Association 269 (15): 1953-59.
13. National institutes of Health, Centers for Disease Control and Prevention (NIH-CDC). 1997. Effective Medical Treatment of Heroin Addiction. NIH Consensus Statement. Bethesda, Maryland: National Institutes of Health.
14. Novick, D.M.; Joseph, H.; Croxson, T.S.; Salsitz, E.A.; Wang, G.; Richmar, B.L.; Poretsky, L.; Keefe, J.B. & Wimbey, E. 1990. Absence of antibody to human immunodeficiency virus in longterm, socially rehabilitated methadone maintenance patients. Archives of Internal Medicine ISO (1);. 97-99.
15. Wesson, D. & Ling, W. 2003. The Clinical Opate Withdrawal Scale (COWS). Journal of Psychoactive Drugs 35 (2): 253-59.\